过敏性鼻炎与细胞因子

被引：5

作者：

陆汉强 ^{[1
]}

程雷 ^{[2
]}

机构：

[1] 南京医科大学第一附属医院江苏省人民医院耳鼻咽喉科

[2] 南京医科大学第一附属医院江苏省人民医院耳鼻咽喉科,南京医科大学国际变态反应研究中心

来源：

中华临床免疫和变态反应杂志 | 2009年 / 3卷 / 03期

关键词：

过敏性鼻炎; T淋巴细胞; 细胞因子;

D O I：

暂无

中图分类号：

R765.21 [鼻炎];

学科分类号：

100213 ;

摘要：

过敏性鼻炎发生发展与功能多样性的辅助性T淋巴细胞(T helper cell,Th)1和Th2有密切关系。本文对过敏性鼻炎患者在局部炎症反应部位产生的T细胞细胞因子和循环T细胞在体外变应原刺激后产生的细胞因子进行综述,并评价抗变态反应药物治疗后细胞因子表达的变化。随着对局部细胞浸润以及局部和全身细胞因子研究的进展,将会对呼吸道变态反应性疾病炎症表型的详细特征有更深入的了解。

引用

页码：203 / 209

页数：7

共 21 条

[1]

Healthy immune response to allergens: T regulatory cells and more[J] . Mübeccel Akdis.Current Opinion in Immunology . 2006 (6)

[2]

Nasal IL-5 levels determine the response to anti–IL-5 treatment in patients with nasal polyps[J] . Philippe Gevaert,Doris Lang-Loidolt,Andreas Lackner,Heinz Stammberger,Heribert Staudinger,Thibaut Van Zele,Gabriele Holtappels,Jan Tavernier,Paul van Cauwenberge,Claus Bachert.The Journal of Allergy and Clinical Immunology . 2006 (5)

[3] Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma [J].

Noga, Oliver ;

Hanf, Gerald ;

Brachmann, Ilka ;

Klucken, Andrea C. ;

Kleine-Tebbe, Jorg ;

Rosseau, Simone ;

Kunkel, Gert ;

Suttorp, Norbert ;

Seybold, Joachim .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (06) :1493-1499

[4]

Topical corticosteroid inhibits interleukin‐4, ‐5 and ‐13 in nasal secretions following allergen challenge[J] . E. M.Erin,A. S.Zacharasiewicz,G. C.Nicholson,A. J.Tan,L. A.Higgins,T. J.Williams,R. D.Murdoch,S. R.Durham,P. J.Barnes,T. T.Hansel.Clinical ＆ Experimental Allergy . 2005 (12)

[5] House dust mite-specific T cells in healthy non-atopic children [J].

Bullens, DMA ;

De Swerdt, A ;

Dilissen, E ;

Kasran, A ;

Kroczek, RA ;

Cadot, P ;

Casaer, P ;

Ceuppens, JL .

CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (12) :1535-1541

[6] The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge [J].

Wagenmann, M ;

Schumacher, L ;

Bachert, C .

ALLERGY, 2005, 60 (09) :1132-1138

[7]

Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: A pilot study[J] . Giorgio Ciprandi,Ignazio Cirillo,Andrea Vizzaccaro,Elisa Civardi,Salvatore Barberi,Michela Allen,Gian Luigi Marseglia.International Immunopharmacology . 2005 (13)

[8]

IL-9 and c-Kit + mast cells in allergic rhinitis during seasonal allergen exposure: Effect of immunotherapy[J] . Kayhan T. Nouri-Aria,Charles Pilette,Mikila R. Jacobson,Hiroshi Watanabe,Stephen R. Durham.The Journal of Allergy and Clinical Immunology . 2005 (1)

[9] TH1-mediated airway hyperresponsiveness independent of neutrophilic inflammation [J].

Cui, JQ ;

Pazdziorko, S ;

Miyashiro, JS ;

Thakker, P ;

Pelker, JW ;

DeClercq, C ;

Jiao, AP ;

Gunn, J ;

Mason, L ;

Leonard, JP ;

Williams, CMM ;

Marusic, S .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (02) :309-315

[10]

Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines[J] . Greg W. Bensch,Harold S. Nelson,Larry C. Borish.Annals of Allergy, Asthma ＆ Immunology . 2002 (5)

← 1 2 3 →